Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:07 pm Sale |
2024-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 2,905,465 6.500% |
-493,282 (-14.51%) |
Filing History |
| 2024-11-14 4:04 pm Sale |
2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 3,398,747 7.800% |
-69,430 (-2.00%) |
Filing History |
| 2024-11-14 11:54 am Purchase |
2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL |
BANK OF AMERICA CORP BAC |
2,157,395 4.900% |
61,314 (+2.93%) |
Filing History |
| 2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL |
Rubric Capital Management LP | 1,333,893 3.050% |
-601,464 (-31.08%) |
Filing History |
| 2024-11-12 09:37 am Purchase |
2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL |
Adage Capital Management L.P. | 2,000,594 4.580% |
2,000,594 (New Position) |
Filing History |
| 2024-05-07 4:52 pm Purchase |
2024-05-03 | 13D | Werewolf Therapeutics, Inc. HOWL |
RA Capital Management, L.P. | 6,192,881 14.200% |
13,846 (+0.22%) |
Filing History |
| 2024-02-14 5:17 pm Purchase |
2024-02-12 | 13D | Werewolf Therapeutics, Inc. HOWL |
RA Capital Management, L.P. | 6,179,035 15.200% |
2,210,452 (+55.70%) |
Filing History |
| 2024-02-14 4:06 pm Purchase |
2023-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 3,468,177 9.600% |
1,646,357 (+90.37%) |
Filing History |
| 2024-02-13 6:58 pm Purchase |
2023-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
BANK OF AMERICA CORP BAC |
2,096,081 5.800% |
2,096,081 (New Position) |
Filing History |
| 2024-02-12 06:06 am Purchase |
2023-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
Rubric Capital Management LP | 1,935,357 5.350% |
99,970 (+5.45%) |
Filing History |
| 2023-12-21 4:30 pm Purchase |
2023-12-11 | 13G | Werewolf Therapeutics, Inc. HOWL |
ADAGE CAPITAL PARTNERS GP L.L.C. | 3,034,255 8.380% |
3,034,255 (New Position) |
Filing History |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
Rubric Capital Management LP | 1,835,387 5.970% |
1,835,387 (New Position) |
Filing History |
| 2023-01-17 4:01 pm Purchase |
2023-01-06 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 1,821,820 5.300% |
528,527 (+40.87%) |
Filing History |
| 2023-01-17 1:20 pm Sale |
2022-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 1,293,293 4.200% |
-223,733 (-14.75%) |
Filing History |
| 2023-01-10 5:11 pm Purchase |
2023-01-06 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 6,159,054 17.960% |
1,854,607 (+43.09%) |
Filing History |
| 2022-08-12 4:32 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 4,304,447 14.570% |
12,566 (+0.29%) |
Filing History |
| 2022-05-02 4:02 pm Purchase |
2022-04-21 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 1,517,026 5.500% |
1,517,026 (New Position) |
Filing History |
| 2022-02-11 4:11 pm Sale |
2021-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
Flynn James E | 958,125 3.470% |
-1,594,662 (-62.47%) |
Filing History |
| 2021-06-16 4:59 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 4,291,881 15.600% |
4,291,881 (New Position) |
Filing History |
| 2021-05-14 5:18 pm Purchase |
2021-05-04 | 13D | Werewolf Therapeutics, Inc. HOWL |
MPM BioVentures 2014, L.P. | 6,731,087 24.400% |
6,731,087 (New Position) |
Filing History |